Groundbreaking research from Tufts University reveals that drugs like Ozempic and Wegovy are dramatically more effective for weight loss than traditional diet and exercise alone, potentially transforming the NHS's approach to the obesity epidemic.
A UK mother's revelation that she uses her disability benefits to pay for weight-loss jabs like Wegovy has ignited a fierce national debate on welfare spending, medical ethics, and obesity treatment.
The World Health Organisation makes a landmark decision, adding weight-loss injections like Wegovy to its Essential Medicines List, signalling a new front in the global fight against obesity.
UK property market continues its remarkable surge as Halifax reports house prices rose 0.9% in September, marking the third straight monthly increase and pushing average prices to a new record high of £293,835.
The NHS in England is set to provide the highly effective Mounjaro (tirzepatide) weight-loss injection, hailed as a major breakthrough in fighting obesity and related diseases like type 2 diabetes.
The NHS is dramatically expanding the availability of prescription weight-loss injections, hailed as a 'game-changer' in treating obesity. This major rollout could benefit hundreds of thousands more patients across England.
Jack Osbourne shuts down speculation he's using diabetes drug Ozempic for weight loss, revealing his dramatic 70lb transformation was achieved through hard work and discipline alone.
Health experts sound the alarm on a worrying new trend where individuals are microdosing powerful diabetes and weight-loss medications like Ozempic to shed pounds, despite severe health risks and a complete lack of evidence for its safety or efficacy.
UK researchers are exploring a revolutionary 'microdosing' strategy for powerful weight-loss medications like Wegovy, potentially slashing costs and side effects while boosting accessibility for NHS patients.
Exclusive investigation reveals the staggering postcode lottery and soaring costs of life-changing obesity drugs like Mounjaro and Wegovy, as the NHS struggles to cope with unprecedented demand.
EXCLUSIVE: Tracey Cox exposes the hidden intimate costs of semaglutide injections. Discover why your marriage and sex life could be the ultimate price for rapid weight loss.
Former Culture Minister Ed Vaizey calls for VAT removal on prescription obesity drugs, arguing it would boost public health and reduce long-term NHS costs.
Ex-Culture Minister Ed Vaizey urges the NHS to widely prescribe revolutionary weight loss injections, calling them a potential 'miracle' for public health and a solution to the obesity crisis.
Exclusive: Medical experts warn of a deepening postcode lottery and a surge in the illegal black market for weight-loss jabs as NHS England struggles with supply and soaring demand for GLP-1 drugs.
Eli Lilly drastically cuts the price of its Mounjaro injection in the UK, making the revolutionary diabetes and weight loss treatment more accessible. The move follows a landmark NHS supply deal.
The MHRA has officially approved the weight-loss injection Mounjaro (tirzepatide) for the UK market, with a set price, marking a significant new option in the nation's battle against obesity.
The weight loss drug Mounjaro (tirzepatide) is launching in the UK, challenging Ozempic. Experts warn of potential shortages and urge prescriptions for those with clinical need, not casual use.
Former President Trump's proposed tariffs could severely restrict UK supplies and drastically increase prices for diabetes and weight-management medications like Ozempic, Wegovy, and Mounjaro, creating a new healthcare crisis.
The UK's medicines watchdog approves the weight loss injection Mounjaro (tirzepatide), offering a powerful new option in the fight against obesity. Discover its price, how it works, and where to get it.
A groundbreaking oral weight loss drug, Orforglipron, has demonstrated dramatic results in a recent clinical trial, offering a potential pill-based alternative to popular injectable treatments like Wegovy. The study shows significant weight reduction, spa
Tennis legend Serena Williams sparks conversation after sharing her use of GLP-1 medication for weight management, challenging stigma and highlighting the personal nature of health decisions.
Exclusive NHS data reveals a shocking rise in children as young as ten being prescribed anti-obesity injections like Wegovy, raising serious safety concerns among medical experts.
A British woman reveals how she lost over four stone using controversial 'fat jab' injections without changing her diet or exercise routine. Exclusive before-and-after photos and expert medical warnings.
The soaring cost of revolutionary new obesity drugs like Wegovy could force the NHS into a stark choice: ration treatments or find billions in new funding. This investigation reveals the immense financial pressure facing the health service.
Tennis legend Serena Williams and Reddit co-founder Alexis Ohanian endorse GLP-1 medications, advocating for their benefits while calling for reduced stigma and improved accessibility in weight management treatment.
A British woman's life-changing weight loss journey using Mounjaro injections has been thrown into turmoil after a dramatic price increase made the drug unaffordable, forcing her to confront the return of debilitating 'food noise'.
Scotland's NHS is spending a staggering £10 million annually on weight-loss injections like Ozempic and Wegovy as the nation battles a severe obesity epidemic. This investigative report reveals the soaring prescription costs and the pressing health challe
A potential second Trump presidency could trigger massive price hikes for life-changing diabetes and obesity medications due to proposed import tariffs, putting essential treatments at risk for millions of Britons.
New research reveals staggering price hikes for matchday essentials at Premier League grounds. Discover which clubs charge the most for your pie and pint.
Exclusive: A dramatic price war has broken out for 'game-changer' weight loss drugs Wegovy and Mounjaro in the UK, making them more accessible through private providers but raising concerns for the NHS.